| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |